Invention Grant
- Patent Title: Chimeric antigen receptors with an optimized hinge region
-
Application No.: US15726943Application Date: 2017-10-06
-
Publication No.: US10556969B2Publication Date: 2020-02-11
- Inventor: Kurt Schönfeld , Christiane Schönfeld , Winfried Wels
- Applicant: CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG-SPEYER-HAUS
- Applicant Address: DE Frankfurt am Main
- Assignee: CHEMOTHERAPETICSHES FORSHUNGSINSTITUT GEORG-SPEYER-HAUS
- Current Assignee: CHEMOTHERAPETICSHES FORSHUNGSINSTITUT GEORG-SPEYER-HAUS
- Current Assignee Address: DE Frankfurt am Main
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP10009345 20100908
- Main IPC: C07K16/46
- IPC: C07K16/46 ; C07K16/32 ; C12N15/70 ; C12N15/62 ; C12N15/63 ; C07K14/725 ; C07K14/705

Abstract:
The present invention relates to multi-functional proteins which comprise (i) a signal peptide, (ii) a target specific recognition domain, (iii) a linker region, connecting domain (ii) and domain (iv) which comprises a specific modified hinge region of the human CD8 alpha-chain, and (iv) an effector domain. The present invention furthermore relates to nucleic acids encoding the proteins, expression constructs for expressing the protein in a host cell and host cells. The proteins of the invention are chimeric antigen receptors with an optimized linker or hinge region that are suitable for generating target-specific effector cells, for use as a medicament, in particular in the treatment of cancer and in adoptive, target-cell specific immunotherapy.
Public/Granted literature
- US20180022828A1 CHIMERIC ANTIGEN RECEPTORS WITH AN OPTIMIZED HINGE REGION Public/Granted day:2018-01-25
Information query